CIVILICA We Respect the Science
(ناشر تخصصی کنفرانسهای کشور / شماره مجوز انتشارات از وزارت فرهنگ و ارشاد اسلامی: ۸۹۷۱)

Comparison of midazolam versus captopril in patients with uncomplicated hypertensive urgency in emergency ward: Double-blind randomized clinical trial

عنوان مقاله: Comparison of midazolam versus captopril in patients with uncomplicated hypertensive urgency in emergency ward: Double-blind randomized clinical trial
شناسه ملی مقاله: JR_RYA-18-4_008
منتشر شده در در سال 1401
مشخصات نویسندگان مقاله:

Mohammad Reza Khorsand - Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
Mostafa Enayatrad - Clinical Research Development Unit, Bahar Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
Seyed Meysam Yekesadat - Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
Maryam Khodayar - Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
Amir Noyani - School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran AND Department of Emergency Medicine, Treetop Hospital, Male, Maldive

خلاصه مقاله:
BACKGROUND: The urgency of uncomplicated blood pressure (BP) is known as a sudden rise in BP. The aim of this study was to evaluate the intravascular administration of midazolam as an emergency care to control BP against captopril in patients with uncomplicated hypertension (HTN).METHODS: The present study was a double-blind parallel randomized clinical trial (RCT) study that was performed on patients with urgent HTN referred to Imam Hossein Hospital in Shahroud, Iran, in ۲۰۱۸. Patients with BP higher than ۱۸۰/۱۱۰ mmHg and with healthy vital organs were selected randomly and allocated into three groups of ۴۳ participants. All patients’ BP in both arms, and after a period of ۱۰ minutes in the left arm, was checked and after administering the medication was checked again for ۴ times of ۱۵ minutes till ۱ hour complete.RESULTS: There were significant differences between systolic (P = ۰.۰۲۴), diastolic (P = ۰.۰۰۱), and mean BP (P = ۰.۰۰۹) in the midazolam group before and after treatment. The group of midazolam and captopril showed the greatest reduction of BP before, in the middle, and after carrying out the treatment methods. As such, systolic, diastolic, and mean BP showed ۲۳.۵% (P = ۰.۰۴۷), ۱۷.۴% (P = ۰.۰۲۱), and ۲۰.۵% (P = ۰.۰۳۱) reduction, respectively.CONCLUSION: Midazolam can be used as an effective and low-risk drug for lowering BP. Midazolam also has a faster effect on lowering BP.

کلمات کلیدی:
Hypertension, Midazolam, Captopril, Emergency Medicine, Clinical Trial

صفحه اختصاصی مقاله و دریافت فایل کامل: https://civilica.com/doc/1873059/